77067
Screening mammography, bilateral
Screening mammography, bilateral. CMS 2026 global wRVU 0.70, total RVU approximately 3.53, Medicare global allowable approximately $118. The annual breast-cancer screening study. Covered with no patient cost share under ACA preventive benefits and Medicare screening rules.
Billing guidance for 77067 is locked
- When to use it: the exact clinical situations that support billing 77067
- Documentation checklist: the 5 elements your note needs before submitting
- Common pitfalls: the 5 mistakes that get 77067 downcoded or denied
Payer notes
Medicare and ACA-compliant commercial plans cover 77067 with no patient cost share when billed as screening (Z12.31 diagnosis). Add 77063 for DBT screening add-on; many payers cover 77063 without separate cost share. Frequency: annual (Medicare every 11 months, commercial typically every 12). If a screening is called back for diagnostic imaging, modifier GG can be used to indicate the screening became diagnostic, preserving the screening cost-share status for Medicare; commercial uses modifier 33 for the equivalent.